Home  >  Products  >  NAT8L (N-acetyltransferase 8-like (GCN5-related, putative) ) Blocking Peptide (the C terminal of NAT8L)(100ug)
NAT8L (N-acetyltransferase 8-like (GCN5-related, putative) ) Blocking Peptide (the C terminal of NAT8L)(100ug)

NAT8L (N-acetyltransferase 8-like (GCN5-related, putative) ) Blocking Peptide (the C terminal of NAT8L)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-NAT8L Antibody (ARP49151_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP49151
Size: 100ug
Weight: 15kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: This gene encodes a single-pass membrane protein, which contains a conserved sequence of the GCN5 or NAT superfamily of N-acetyltransferases and is a member of the N-acyltransferase (NAT) superfamily. This protein is a neuron-specific protein and is the N-acetylaspartate (NAA) biosynthetic enzyme, catalyzing the NAA synthesis from L-aspartate and acetyl-CoA. NAA is a major storage and transport form of acetyl coenzyme A specific to the nervous system. The gene mutation results in primary NAA deficiency (hypoacetylaspartia).
Alternative names: CML3; FLJ37478; MGC117272; NAT8-LIKE
See Full Product Listings >